In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences Company) about the possibilities lateral flow assays offer in both the present and potential ...

Add Yahoo as a preferred source to see more of our stories on Google. As a result of the rapidly-spreading Omicron variant, Covid case numbers have continued to rise across the UK in record numbers, ...

The global lateral flow assay (LFA) market is projected to grow from USD 10.01 billion in 2024 to USD 15.42 billion by 2030, driven by increasing demand for point-of-care testing and the rising ...

In our best practices blog, we explore how lateral flow assay design affects test performance. Read on to gain a deeper understanding of the development process, enabling you to streamline the ...

In a recent review published in Nature Reviews Bioengineering, researchers assessed the changing landscape of lateral flow tests (LFTs), and the development of next-generation LFTs based on lessons ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces a major technical milestone with the successful detection of nucleosomes in capillary blood ...

Just as we thought we understood COVID testing, along came omicron and raised a whole new bunch of questions. We asked Dr Andrew Lee, a reader in global public health, to answer them. The UK ...

Silica-gold nanoshells highlight how good probe design can boost assay performance. A series of rodent experiments showed that even with abundant food and water, personal space is essential to prevent ...